MESO - Mesoblast

-

$undefined

N/A

(N/A)

Mesoblast NASDAQ:MESO

Location: L 38 55 Collins St, Victoria, 3000, Australia | Website: http://www.mesoblast.com/ | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

7.154B

Cash

62.96M

Avg Qtr Burn

-12.11M

Short % of Float

0.18%

Insider Ownership

0.07%

Institutional Own.

1.37%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
RYONCIL™ (Remestemcel-L) Details
Acute graft-versus host disease

PDUFA

Approval decision

REVASCOR® (Rexlemestrocel) Details
Heart disease, Hypoplastic Left Heart Syndrome

BLA

Acceptance for review

REVASCOR® (Rexlemestrocel) Details
Heart disease, Heart failure

BLA

FDA meeting

Rexlemestrocel Details
Chronic lower back pain

Phase 3

Update

Remestemcel-L Details
Inflammatory bowel disease, Bowel disorder, Crohns disease

Failed

Discontinued

Failed

Discontinued